Nektar Therapeutics shares owned by Balyasny Asset Management
Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Balyasny Asset Management
from 13F filings
Historical chart of Balyasny Asset Management investment in Nektar Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Nektar Therapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Nektar Therapeutics by Balyasny Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $391k | 300k | 1.30 |
| 2024-06-30 | $327k | 264k | 1.24 |
| 2024-03-31 | $280k | 300k | 0.93 |
| 2023-12-31 | $622k | 1.1M | 0.57 |
| 2023-09-30 | $794k | 1.3M | 0.60 |
| 2023-06-30 | $26k | 45k | 0.58 |
| 2022-09-30 | $46k | 15k | 3.17 |
| 2022-03-31 | $3.6M | 669k | 5.39 |
| 2021-12-31 | $412k | 31k | 13.52 |
| 2021-09-30 | $3.1M | 174k | 17.96 |
| 2019-12-31 | $2.9M | 134k | 21.58 |
| 2019-06-30 | $5.8M | 162k | 35.58 |
| 2019-03-31 | $5.8M | 173k | 33.60 |
| 2018-12-31 | $3.3M | 100k | 32.87 |
| 2018-09-30 | $12M | 204k | 60.96 |
| 2018-03-31 | $4.2M | 39k | 106.26 |
| 2017-12-31 | $14M | 229k | 59.72 |
| 2017-09-30 | $19M | 793k | 24.00 |
| 2017-06-30 | $10M | 511k | 19.55 |
| 2017-03-31 | $10M | 438k | 23.47 |
| 2015-12-31 | $500k | 30k | 16.87 |
| 2015-06-30 | $201k | 16k | 12.51 |